ORINDA, Calif., Nov. 17, 2023 /PRNewswire/ — CG Pharmaceuticals announces the commencement of Phase 2 study for metastatic pancreatic ductal adenocarcinoma (PDAC) with the recommended Phase 2 dose (RP2D) of ivaltinostat (ClinicalTrials.gov ID NCT05249101). Continue Reading The RP2D of ivaltinostat (250 mg/m2) was determined by the Safety Review Committee (SRC) following a thorough safety data… Continue reading CG Pharmaceuticals Announces the Commencement of Phase 2 Study for Metastatic Pancreatic Cancer
Category: Newswire
Indonesia Buy Now Pay Later Business Report 2023: BNPL Payments are Expected to Grow by 20.6% to Reach $4.4 Billion this Year – Market Forecast to 2028
DUBLIN , Nov. 17, 2023 /PRNewswire/ — The “Indonesia Buy Now Pay Later Business and Investment Opportunities Databook – 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis, Business Model, Demographics – Q2 2023 Update” report has been added to ResearchAndMarkets.com’s offering. BNPL payments in Indonesia are expected to grow by 20.6% on an annual… Continue reading Indonesia Buy Now Pay Later Business Report 2023: BNPL Payments are Expected to Grow by 20.6% to Reach $4.4 Billion this Year – Market Forecast to 2028
Sanyou’s “STAL Platform” is a significant advancement in the field of drug discovery.
SHANGHAI, Nov. 17, 2023 /PRNewswire/ — Sanyou’s “STAL Innovative Biologics Drug Discovery Platform” is a significant advancement in the field of drug discovery. This cutting-edge platform enables the screening of thousands of innovative lead molecules against a common target, surpassing the capacity of conventional methods. We will highlight three key innovations that can help reshape… Continue reading Sanyou’s “STAL Platform” is a significant advancement in the field of drug discovery.
Asep Inc. in Final Stage of Approval Process for NASDAQ Listing Registration Statement
VANCOUVER, BC, Nov. 17, 2023 /PRNewswire/ – Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce it is in the final stage of its approval process for the draft registration statement on Form F-1 which was filed with the U.S. Securities and Exchange Commission (the “SEC”)… Continue reading Asep Inc. in Final Stage of Approval Process for NASDAQ Listing Registration Statement
Kansas City Royals Tickets on Sale at Tickets For Less
OVERLAND PARK, Kan., Nov. 17, 2023 /PRNewswire/ — Tickets are officially on sale for the 2024 Kansas City Royals season! Fans can secure their seats at ticketsforless.com to watch the team in action, starting when the Royals host the Minnesota Twins for Opening Day on March 28. “It’s going to be another exciting season at… Continue reading Kansas City Royals Tickets on Sale at Tickets For Less
Blue Diamond Growers 113th “Growing Together” Annual Meeting Highlights a Year of Resilience
Blue Diamond Growers CEO, Kai Bockmann, Acknowledges Industry Challenges and Outlines Strategic Growth Plan SACRAMENTO, Calif., Nov. 17, 2023 /PRNewswire/ — At the 113th Blue Diamond Growers “Growing Together” Annual Meeting on Nov. 15 in Modesto, Blue Diamond Growers’ CEO, Kai Bockmann, reflected on his first ten months in the leadership role by acknowledging significant challenges… Continue reading Blue Diamond Growers 113th “Growing Together” Annual Meeting Highlights a Year of Resilience
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DMTK
NEW YORK, Nov. 17, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, both dates inclusive (the “Class Period”), of the important December 15, 2023 lead plaintiff deadline. SO WHAT: If you purchased DermTech securities during… Continue reading ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DMTK
Finland Buy Now Pay Later Business Report 2023: BNPL Payments to Grow by 18.4% to Reach $3.4 Billion this Year – Market Forecasts to 2028
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Finland Buy Now Pay Later Business and Investment Opportunities Databook – 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis, Business Model, Demographics – Q2 2023 Update” report has been added to ResearchAndMarkets.com’s offering. BNPL payments in Finland are expected to grow by 18.4% on an annual… Continue reading Finland Buy Now Pay Later Business Report 2023: BNPL Payments to Grow by 18.4% to Reach $3.4 Billion this Year – Market Forecasts to 2028
Medtronic announces FDA approval of minimally invasive device to treat hypertension
The Symplicity™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology DUBLIN, Nov. 17, 2023 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food… Continue reading Medtronic announces FDA approval of minimally invasive device to treat hypertension
BARSELE MINERALS CLOSES PRIVATE PLACEMENT
VANCOUVER, BC, Nov. 17, 2023 /PRNewswire/ – Barsele Minerals Corp. (the “Company” or “Barsele“) (TSXV: BME) (OTC: BRSLF) is pleased to announce the closing of a non-brokered private placement (the “Offering“). The Offering consisted of the sale of 2,000,667 units of the Company (the “Units“) at a price of $0.15 per Unit for aggregate gross proceeds… Continue reading BARSELE MINERALS CLOSES PRIVATE PLACEMENT